カテゴリー： 世界, 医療/バイオ, LP Information

世界の動物用ワクチン市場予測 2023年-2029年

【英語タイトル】Global Veterinary Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08785）・商品コード：LP23DC08785
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：124
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の動物用ワクチン市場」は、過去の販売実績から2022年の世界の動物用ワクチンの総販売量を検討し、2023年から2029年の予測される動物用ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の動物用ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の動物用ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の動物用ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の動物用ワクチン市場における各社の独自のポジションをより深く理解するために、動物用ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の動物用ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。動物用ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。動物用ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。動物用ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

動物用ワクチンの世界主要メーカーとしては、Merck、 Zoetis、 Boehringer Ingelheim、 Ceva、 CAHIC、 HVRI、 Ringpu Biology、 Yebio、 DHN、 WINSUN、 Elanco、 Virbac、 Jinyu Bio-Technology、 ChengDu Tecbond、 CAVAC、 Kyoto Biken Laboratories、 FATRO、 Vaksindo、 Bio-Labs、 Avimex Animal Health、 MEVAC、 Biovac、 Atafen、 Dyntec、 RVSRI、 Medionなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の動物用ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では動物用ワクチン市場をセグメンテーションし、種類別 (弱毒生ワクチン、不活化ワクチン、その他)、用途別 (家畜、コンパニオンアニマル)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：弱毒生ワクチン、不活化ワクチン、その他

・用途別区分：家畜、コンパニオンアニマル

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の動物用ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た動物用ワクチン市場成長の要因は何か？
・動物用ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・動物用ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：動物用ワクチンの年間販売量2018-2029、地域別現状・将来分析
・動物用ワクチンの種類別セグメント：弱毒生ワクチン、不活化ワクチン、その他
・動物用ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・動物用ワクチンの用途別セグメント：家畜、コンパニオンアニマル
・動物用ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の動物用ワクチン市場
・企業別のグローバル動物用ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の動物用ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の動物用ワクチン販売価格
・主要企業の動物用ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

動物用ワクチンの地域別レビュー
・地域別の動物用ワクチン市場規模2018-2023：年間販売量、売上
・主要国別の動物用ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの動物用ワクチン販売の成長
・アジア太平洋の動物用ワクチン販売の成長
・ヨーロッパの動物用ワクチン販売の成長
・中東・アフリカの動物用ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の動物用ワクチン販売量、売上（2018-2023）
・南北アメリカの動物用ワクチンの種類別販売量
・南北アメリカの動物用ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の動物用ワクチン販売量、売上（2018-2023）
・アジア太平洋の動物用ワクチンの種類別販売量
・アジア太平洋の動物用ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の動物用ワクチン販売量、売上（2018-2023）
・ヨーロッパの動物用ワクチンの種類別販売量
・ヨーロッパの動物用ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の動物用ワクチン販売量、売上（2018-2023）
・中東・アフリカの動物用ワクチンの種類別販売量
・中東・アフリカの動物用ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・動物用ワクチンの製造コスト構造分析
・動物用ワクチンの製造プロセス分析
・動物用ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・動物用ワクチンの主要なグローバル販売業者
・動物用ワクチンの主要なグローバル顧客

地域別の動物用ワクチン市場予測レビュー
・地域別の動物用ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・動物用ワクチンの種類別市場規模予測
・動物用ワクチンの用途別市場規模予測

主要企業分析
Merck、 Zoetis、 Boehringer Ingelheim、 Ceva、 CAHIC、 HVRI、 Ringpu Biology、 Yebio、 DHN、 WINSUN、 Elanco、 Virbac、 Jinyu Bio-Technology、 ChengDu Tecbond、 CAVAC、 Kyoto Biken Laboratories、 FATRO、 Vaksindo、 Bio-Labs、 Avimex Animal Health、 MEVAC、 Biovac、 Atafen、 Dyntec、 RVSRI、 Medion
・企業情報
・動物用ワクチン製品
・動物用ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Veterinary Vaccine market size is projected to grow from US$ 10570 million in 2022 to US$ 17200 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
LPI (LP Information)’ newest research report, the “Veterinary Vaccine Industry Forecast” looks at past sales and reviews total world Veterinary Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine sales for 2023 through 2029. With Veterinary Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segmentation by application
Farm Animal
Companion Animal
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2018-2023)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2018-2023)
3 Global Veterinary Vaccine by Company
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Vaccine Revenue by Company (2018-2023)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Vaccine by Geographic Region
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 Americas
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2018-2023)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2018-2023)
5.2 Americas Veterinary Vaccine Sales by Type
5.3 Americas Veterinary Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2018-2023)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2018-2023)
6.2 APAC Veterinary Vaccine Sales by Type
6.3 APAC Veterinary Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2018-2023)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2018-2023)
7.2 Europe Veterinary Vaccine Sales by Type
7.3 Europe Veterinary Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type
8.3 Middle East & Africa Veterinary Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 World Forecast Review for Veterinary Vaccine by Geographic Region
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2024-2029)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Vaccine Forecast by Type
12.7 Global Veterinary Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
13.26 Medion
13.26.1 Medion Company Information
13.26.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.26.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Medion Main Business Overview
13.26.5 Medion Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share by Type (2018-2023)
Table 8. Global Veterinary Vaccine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
Table 10. Global Veterinary Vaccine Sale Price by Type (2018-2023) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 12. Global Veterinary Vaccine Sales Market Share by Application (2018-2023)
Table 13. Global Veterinary Vaccine Revenue by Application (2018-2023)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2018-2023)
Table 15. Global Veterinary Vaccine Sale Price by Application (2018-2023) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2018-2023) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2018-2023)
Table 18. Global Veterinary Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2018-2023)
Table 20. Global Veterinary Vaccine Sale Price by Company (2018-2023) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2018-2023) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2018-2023)
Table 36. Americas Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2018-2023)
Table 38. Americas Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 39. Americas Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
Table 41. APAC Veterinary Vaccine Sales Market Share by Region (2018-2023)
Table 42. APAC Veterinary Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Veterinary Vaccine Revenue Market Share by Region (2018-2023)
Table 44. APAC Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 45. APAC Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 46. Europe Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Country (2018-2023)
Table 48. Europe Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Country (2018-2023)
Table 50. Europe Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 52. Middle East & Africa Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 53. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 57. Middle East & Africa Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 59. Key Market Challenges & Risks of Veterinary Vaccine
Table 60. Key Industry Trends of Veterinary Vaccine
Table 61. Veterinary Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Vaccine Distributors List
Table 64. Veterinary Vaccine Customer List
Table 65. Global Veterinary Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 66. Global Veterinary Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 68. Americas Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Veterinary Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 70. APAC Veterinary Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 72. Europe Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 74. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Veterinary Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
Table 76. Global Veterinary Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Veterinary Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
Table 78. Global Veterinary Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 81. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 86. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 87. Zoetis Main Business
Table 88. Zoetis Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 96. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 101. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 106. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 116. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 121. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 126. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 131. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 132. Elanco Main Business
Table 133. Elanco Latest Developments
Table 134. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 136. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 151. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 157. Kyoto Biken Laboratories Main Business
Table 158. Kyoto Biken Laboratories Latest Developments
Table 159. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 161. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 177. Avimex Animal Health Main Business
Table 178. Avimex Animal Health Latest Developments
Table 179. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 181. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 182. MEVAC Main Business
Table 183. MEVAC Latest Developments
Table 184. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 186. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 187. Biovac Main Business
Table 188. Biovac Latest Developments
Table 189. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 191. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 192. Atafen Main Business
Table 193. Atafen Latest Developments
Table 194. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 196. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 197. Dyntec Main Business
Table 198. Dyntec Latest Developments
Table 199. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 201. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 202. RVSRI Main Business
Table 203. RVSRI Latest Developments
Table 204. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 205. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 206. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 207. Medion Main Business
Table 208. Medion Latest Developments
List of Figures
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2018-2029 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Product Picture of Other
Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2022
Figure 13. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
Figure 14. Veterinary Vaccine Consumed in Farm Animal
Figure 15. Global Veterinary Vaccine Market: Farm Animal (2018-2023) & (M Doses)
Figure 16. Veterinary Vaccine Consumed in Companion Animal
Figure 17. Global Veterinary Vaccine Market: Companion Animal (2018-2023) & (M Doses)
Figure 18. Global Veterinary Vaccine Sales Market Share by Application (2022)
Figure 19. Global Veterinary Vaccine Revenue Market Share by Application in 2022
Figure 20. Veterinary Vaccine Sales Market by Company in 2022 (M Doses)
Figure 21. Global Veterinary Vaccine Sales Market Share by Company in 2022
Figure 22. Veterinary Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Veterinary Vaccine Revenue Market Share by Company in 2022
Figure 24. Global Veterinary Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Veterinary Vaccine Sales 2018-2023 (M Doses)
Figure 27. Americas Veterinary Vaccine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Veterinary Vaccine Sales 2018-2023 (M Doses)
Figure 29. APAC Veterinary Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Veterinary Vaccine Sales 2018-2023 (M Doses)
Figure 31. Europe Veterinary Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Veterinary Vaccine Sales 2018-2023 (M Doses)
Figure 33. Middle East & Africa Veterinary Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Veterinary Vaccine Sales Market Share by Country in 2022
Figure 35. Americas Veterinary Vaccine Revenue Market Share by Country in 2022
Figure 36. Americas Veterinary Vaccine Sales Market Share by Type (2018-2023)
Figure 37. Americas Veterinary Vaccine Sales Market Share by Application (2018-2023)
Figure 38. United States Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Veterinary Vaccine Sales Market Share by Region in 2022
Figure 43. APAC Veterinary Vaccine Revenue Market Share by Regions in 2022
Figure 44. APAC Veterinary Vaccine Sales Market Share by Type (2018-2023)
Figure 45. APAC Veterinary Vaccine Sales Market Share by Application (2018-2023)
Figure 46. China Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Veterinary Vaccine Sales Market Share by Country in 2022
Figure 54. Europe Veterinary Vaccine Revenue Market Share by Country in 2022
Figure 55. Europe Veterinary Vaccine Sales Market Share by Type (2018-2023)
Figure 56. Europe Veterinary Vaccine Sales Market Share by Application (2018-2023)
Figure 57. Germany Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Veterinary Vaccine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2022
Figure 72. Manufacturing Process Analysis of Veterinary Vaccine
Figure 73. Industry Chain Structure of Veterinary Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Veterinary Vaccine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Veterinary Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Veterinary Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の動物用ワクチン市場予測 2023年-2029年] (コード：LP23DC08785)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の動物用ワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の反芻動物ワクチン市場予測 2023年-2029年
  • 世界のワクチン製造装置市場予測 2023年-2029年
  • 世界の経口ワクチン投与市場予測 2023年-2029年
  • 世界の経口投与ワクチン市場予測 2023年-2029年
  • 世界のmRNA新型コロナウイルスワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆